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A b s t r a c t  
The present investigation attempted to prepare and evaluate the finasteride ethosomes for 
transdermal drug delivery. The ethosomal formulations were developed using different concentrations 
of ethanol (20-60%) and soya lecithin (1-5%). In-vitro release studies of formulation containing 30% 
ethanol and 3% soya lecithin showed highest % drug release (82.66%) with highest transdermal flux. 
The entrapment efficiency and drug content of optimized formulation were found to be 85.32% and 
99.5% respectively. Scanning Electron micrographs revealed that the formed vesicles were spherical 
in shape with uniform size. It was also observed that concentration of the ethanol had profound 
influence on entrapment efficiency. The drug release from the formed vesicles was found to follow first 
order kinetics with higuchi diffusion mechanism. The transdermal delivery of finasteride could be 
potentially enhanced when they were formulated into ethosomes. This ethosomal drug delivery was 
found to be promising than could be a nanogel.   
Keywords: Finasteride, ethosomes, Scanning electron microscopy, transdermal delivery, Zeta 
potential.  
 
 
 
Introduction 
Transdermal drug delivery system (TDDS) showed promising result 
in comparison to oral drug delivery system as it eliminates 
gastrointestinal involvement and first pass metabolism of the drug. 
The skin acts as a major target as well as a principle barrier for 
topical/ transdermal drug delivery. Stratum corneum (SC) permits 
only the lipophilic drugs having molecular weight < 500 daltons [1] 
and acts as a barrier. Many approaches have been attempted to 
overcome this property of skin, includes the use of chemical 
enhancers like surfactants, organic solvents, physical enhancers 
such as iontophoresis, sonophoresis, microneedles, electroporation 
etc. and various methods have been assessed to increase 
permeation and amongst them the best is lipid vesicles can modulate 
barrier property of SC [2,3]. Vesicles act as carrier systems, able to 
transport large molecular weight drugs into the skin or even into the 
systemic circulation [4]. 
     Conventional liposomes have been generally reported as carriers 
of drugs with minimal diffusion into deeper tissues, due to their large 
size and lack of flexibility [5,6]. After meticulous research over the 
decades led to the development of a new class of lipid vesicles that 
are shows ultra-elastic property and were considered as ethosomes. 
Touitou et al., (1998) discovered lipid vesicular systems embedding 
ethanol in relatively with higher concentration [7]. Ethosomes are 
novel lipid carriers comprised ethanol, phospholipid, bile salts, 
surfactants and water [8]. These were show augmented permeation 
through the skin due to the escalated fluidity of SC lipids [9,10]. 
Further, due high flexibility of ethosomal membranes by excess 
ethanol, these are squeezed into the skin their self through pores, 
became much smaller than their actual size. Ethosomes are soft, 
flexible vesicles and considerable dosage forms can efficiently load 
higher quantities of drug, permeate in depth to the skin than 
conventional liposomes [11-13].  
     Finasteride is a type-II 5α-reductase inhibitor, N-(1,1-
dimethylethyl)-3-oxo-4-aza-5α-androst-1-ene, (5α, 17β) 
carboxamide [14] and is used in the treatment of androgenic 
alopecia and as surgical alternative for benign prostatic hyperplasia. 
The oral bioavailability of finasteride is 65%, mean half-life is 4.5 h 
and 8h in men 18-60 and 70 years of age respectively.  In this study, 
transdermal drug delivery system of ethosomes was designed and 
developed with finasteride. Effects of various excipients on the 
incompatibility, entrapment efficiency, drug release, percutaneous 
absorption, stability studies were evaluated. Characterization of 
ethosomes was performed by using SEM, micorscopic examination, 
zetapotential and size distribution. Physical properties of ethosomal 
gel were evaluated such as organoleptic characters, washability, 
spreadability, viscosity, pH and drug content uniformity. Further, 
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studied skin irritation test, in-vitro drug release by dialysis membrane 
and correlated with ex-vivo drug release on rat skin. 
Materials and Methods 
Finasteride was obtained as a gift sample from Aurobindo Phama 
Ltd., Hyderabad, India. propylene glycol, L-soya lecithin, carbopol-
934, cholesterol, ethanol and triethanol amine were procured from 
SD fine chem. Ltd., Mumbai, India. Other chemicals and reagents 
used were of analytical grade. 
Analysis of Finasteride drug in vesicles 
Calibration curve was constructed using UV Spectrophotometer in the 
concentration range of 5-25 μg/mL for Finasteride and plotted a linear 
curve between absorbance vs. concentration (μg/mL) at 254 nm 
(Figure. 1). 
Compatibility Studies 
IR spectroscopy was used to investigate interactions between 
different components in the formulation. One part of the sample and 
three parts of potassium bromide were taken in a mortar and triturated 
well. A small amount of triturated sample was taken into a pellet 
maker and was compressed at 10 kg/cm2 using hydraulic press 
(Bruker). The pellet was kept on to the sample holder and scanned 
from 400 to 4000 cm-1 in IR spectrophotometer. The spectrum 
obtained was compared with original spectra of drug and optimized 
formulation. 
Preparation of finasteride loaded ethosomes and 
ethosomal gel 
The ethosomes loaded with finasteride were prepared by the cold 
method followed by ultra-sonication according to Touitou et al., (1999) 
[12]. In brief, phospholipid (L-soya lecithin), cholesterol and the drug 
were blended and dissolved in ethanol in a covered vessel with 
vigorous stirring at 700 rpm at room temperature. Propylene glycol 
was added at 40°C mixed; later water was added and whole mixture 
was stirred for 5 min in a covered vessel. Size reduction was done by 
sonication and the suspension was stored in refrigerator. The 
composition of ethosomal formulations of finasteride were tabulated 
in table 1. The ethosomal vesicles suspension was incorporated into 
carbopol gel 934 (1%, 1.5%, 2% w/w) slowly to ultrapure water and 
kept for 20 min. Triethanolamine was added to it drop wise and pH 
was adjusted to 7.4. The composition of ethosomal gel was given in 
table 2. 
 
Table 1. Composition of various ethosomal formulations of finesteride drug 
Formulation Code Finasteride (mg) L-Soya lecithin 
(%) 
Cholesterol  
(mg) 
Ethanol 
  (%) 
Propylene glycol 
(%) 
Water 
(mL) 
F1 5 2 5 20 10 Q.S 
F2 5 2.5 5 20 10 Q.S 
F3 5 3 5 20 10 Q.S 
F4 5 3.5 5 20 10 Q.S 
F5 5 4 5 20 10 Q.S 
F6 5 4.5 5 20 10 Q.S 
F7 5 5 5 20 10 Q.S 
F8 5 5.5 5 20 10 Q.S 
F9 5 6 5 20 10 Q.S 
F10 5 3 5 30 10 Q.S 
F11 5 3 5 30 15 Q.S 
F12 5 3 5 30 20 Q.S 
F13 5 3 5 30 25 Q.S 
F14 5 3 5 30 30 Q.S 
F15 5 3 5 40 20 Q.S 
F16 5 3 5 50 20 Q.S 
F17 5 3 5 60 20 Q.S 
F18 5 3 5 20 20 Q.S 
F19 5 3 10 30 20 Q.S 
F20 5 3 --- 30 20 Q.S 
F11a (F.S) 5 --- ---        --- --- Q.S 
F11b*      5 ---          5     30 ---  Q.S 
F.S= Free Suspension, F11* = Effect of stabilizer on optimized formula. 
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Entrapment Efficiency 
The amount of finasteride encapsulated per unit weight of the 
ethosomes was determined after separation of the free drug and 
solid lipids from the aqueous medium. Ultracentrifugation was 
performed at 4C, at 40,000 rpm for 3 h (Touitou et al., 1998) [7] and 
suspension was assayed both in the sediment and in the 
supernatant. The entrapment efficiency was calculated from the 
relationship: 
100
T
C-T
EE 
     (1) 
Where, T is the total amount of drug that is detected both in the 
supernatant and sediment, C is the amount of drug detected only in 
the supernatant. 
 
Table 2. Composition of different ethosomal gel formulations 
Formulation Carbopol D 934  
  (%) 
Ethosomal 
Suspension (ml) 
Triethanol amine (ml) Water 
F11a 1 20 0.05 Q.S 
F11b 1.5 20 0.05 Q.S 
F11c 2 20 0.05 Q.S 
F11b* 1.5 Free Drug (0.005g) 0.05 Q.S 
F11b*= Free drug gel. 
 
Characterization of Ethosomes 
Microscopic Examination of Particle Size and Shape 
 Microscopic analysis was performed to determine the average size 
of ethosomes [7]. A sample of ethosomes was suitably diluted with 
distilled water in order to observe individual vesicle and a drop of 
diluted suspension was put on a glass slide covered with cover slip 
and examined under microscope (magnification 15 × 45 X ). All 
measurements were performed in triplicates and the formed vesicles 
were spherical in shape. 
Scanning Electron Microscopic Studies 
The ethosomal dispersion was diluted appropriately and sonicated. 
Few drops of the dispersion were placed on the grid and allowed to 
dry [15]. After the samples were dried thoroughly, the Images were 
recorded on a scanning electron micrograph (magnification: 60x, 
accelerating voltage: 12.0kV and at 25±2°C).  
Zeta Potential Analysis 
Zeta potential is the measure of the magnitude of the electrostatic or 
the charge repulsion or attraction between particles. The zeta 
potential was determined using zeta potential analyzer (nano-
particle analyzer SZ-100) at 25°C. Electrophoretic mobility and 
mean zeta potential values were obtained directly from the 
measurement. 
Size Distribution 
The size of ethosomes ranges between tens of nanometers to 
microns and is influenced by the composition of the formulation. 
Particle size of vesicle can be determined by dynamic light scattering 
(DLS) and also can be characterized by light microscopy with an 
eyepiece micrometer which is calibrated with a stage micrometer. 
The diameters of 150 vesicles were determined randomly using 
calibrated eyepiece micrometer with stage micrometer.  The average 
diameter was calculated using the formula [16]. 
Sn
Snd
diameter Average 
                (2) 
Where; n = number of vesicles, d = diameter of vesicles 
  
Characterization and Evaluation of Ethosomal Gel 
Determination of Organoleptic Characters, 
Washability and Spreadability 
The formulations were tested for their organoleptic properties like 
color, odor, texture, phase separation and feel upon application 
(grittiness, greasiness). Washability of the gel was determined by a 
small quantity of gel was applied on the skin. After washing with 
water it is checked for whether the gel was completely washed out 
or not. Spreadability was determined by using modified wooden 
block and glass slide apparatus. A measured amount of gel (0.5 g) 
was placed on fixed glass slide with a circle of 1cm diameter; the 
movable pan with a glass slide attached to it and was placed over 
the fixed glass slide, such that the gel was sandwiched between the 
two glass slides for 5min. The increase in the diameter due to 
spreading of the gel was noted and spreadability was determined 
using the formula. 
T
M
S          (3) 
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Where, S is the Spreadability in g/s, M is the mass in grams and T is 
the time in seconds. The viscosity of ethosomal gel was determined 
by brook field viscometer with T-bar spindle (Sindle C, S-96). The 
spindle was rotated at 50rpm and recorded the readings after 30 sec.                       
pH, Percentage Drug Content and Content drug 
Uniformity 
Solution of 1g of gel dissolved in 30mL of distilled water was 
prepared and pH was determined by using digital pH meter 
(Systronics 361) and the results were summarized in the table 3. The 
drug Content Uniformity [17] was determined 1g of gel was dissolved 
in a 100 mL of phosphate buffer pH 7.4 for 48 h with constant stirring 
using magnetic stirrer. Samples were taken from three different parts 
of the total ethosomal gel of 1g. Solution was then filtered and 
recorded the absorbance with UV-spectrophotometer at λmax 254nm.  
Skin irritation test 
The developed formulations were tested for primary skin irritation on 
rats (male Wistar rats). The rats were taken and the abdominal skin 
of the rat was clipped free of hair 24 h prior to the formulation 
application. 0.5 g of each formulation was applied on the hair-free 
skin of rat by uniform spreading over an area of 4 cm2. The skin 
surface was observed for visible changes such as erythema after 24, 
48 and 72 h of the formulation application. The mean erythemal 
scores were recorded depending on the degree of erythema: no 
erythema = 0, slight erythema (barely perceptible- light pink) = 1, 
moderate erythema (dark pink) = 2, moderate to severe erythema 
(light red) = 3 and severe erythema (extreme redness) = 4. 
Stability studies 
Stability study was carried out for finasteride ethosomal preparation 
by using stability chamber (Thermo lab, India-standard) at two 
different temperatures i.e. refrigeration temperature (4±2°C) and at 
room temperature (27±2°C) for 9 weeks. The formulations subjected 
for stability were stored in borosilicate container and were analyzed 
for any physical changes such as color and appearance, for any 
chemical changes such as the In-vitro percentage drug release [18].  
Drug release studies 
In-vitro release kinetics by using dialysis membrane 
In-vitro drug release studies were performed using a modified Franz 
diffusion cell. The membrane was soaked in double distilled water 
for 12 h before mounting on a Franz diffusion cell [19]. The effective 
permeation area of the diffusion cell and receptor cell volume was 
2.4 cm and 200 mL respectively. The temperature was maintained 
at 37±0.5°C. The receptor compartment contained 200 mL of pH 7.4 
buffer and was constantly stirred by magnetic stirrer at 800 rpm.  
Prepared dialysis membrane was mounted between the donor and 
the receptor compartments. The optimized ethosomal gel (0.5 g) 
was applied to the dialysis membrane and the content of diffusion 
cell was kept under constant stirring then 5 mL of samples were 
(replenished with equal volume of fresh pH 7.4 buffer) withdrawn 
from receptor compartment of diffusion cell at predetermined time 
intervals and analyzed by spectrophotometric method at 254 nm 
after suitable dilution. The in-vitro data was fitted into various kinetic 
models i.e. zero order, first order, Higuchi, Korsmeyer-Peppa’s 
models.  
Ex-vivo Drug Diffusion Study Using Rat Skin 
Skin permeation of finasteride ethosomal gel was studied using 
freshly excised hairless abdominal skin of a male wistar rat (250 g, 
8 weeks), which was housed individually in the animal house with 
food and water. The rat was sacrificed by decapitation. Then, the 
hairs in the abdominal area of the animal were carefully cut as short 
as possible with scissors. The skin was surgically removed, cleaned 
of muscle, fat and vasculature, and kept at –4°C for 24 h before the 
experiment. Skin samples were mounted on a modified franz 
diffusion cell (A = 0.785 cm2) with the dermal skin surface exposed 
to the receiver phase and the stratum corneum remained in contact 
with the donor compartment. 
 
Results and Discussion 
Analysis of Finasteride drug in vesicles 
Calibration graph was constructed for Finasteride by plotting 
absorbance vs. concentration (μg/mL) at 254 nm (Figure. 1). 
Correlation coefficient (r2) was calculated in order to find the degree 
of linear relationship and was found to be 0.998. A mathematical 
form of linear relationship was obtained as y = 0.021x + 0.004 
between the two variables i.e. absorbance vs concentration. 
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Figure. 1. Calibration curve of Finasteride at 254 nm 
 
FTIR Studies 
 IR spectra was compared and checked for any shifting in functional 
peaks and non-involvement of functional group. The sharp peaks at 
3428.45 and 3242.39 cm-1 designated as –N–H stretches of pure 
drug and slightly shifted to 3431.56 and 3243.52 cm-1 respectively 
which are not showing considerable changes. The peaks at 2849.26 
and 815.48 cm-1 noted as –C–H bending and stretching 
respectively, no changes were observed. Further, a peak at 1687.75 
cm-1 due to –C=O and there is no change after formulating of 
finasteride ethosomal gel. The other peaks appeared after 
formulation due to the excipients added. From the spectra various 
peaks of drug, physical mixture of drug and excipients studied, it is 
clear that there is no interaction between the selected carriers, drug 
and mixtures (Figure. 2). 
 
Figure. 2. FTIR Spectra of (a) pure finasteride drug (b) final optimized ethosomal gel 
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Entrapment Efficiency 
For all formulations drug content, entrapment efficiency and pH were 
determined and were tabulated in table 3. The maximum entrapment 
efficiency of ethosomal vesicles was 85.32% for ethosomal 
formulation containing 30% ethanol which was almost double to the 
formulation containing 60% ethanol (F11). As the ethanol 
concentration increased from 20% to 60% w/w, there was increase 
in the entrapment efficiency and with further increase in the ethanol 
concentration (>30% w/w) the vesicle membrane becomes more 
permeable that lead to decrease in the entrapment efficiency. 
Results of entrapment efficiency also suggest that 3% phospholipid 
is optimal concentration for entrapment efficiency [20] and increased 
or decreased in concentration of phospholipid reduces the 
entrapment efficiency of vesicles (table 3). 
 
Table 3. Drug entrapment efficiency, % Drug content and pH of Finasteride Ethosomal Gels 
 
Formulation 
code 
Entrapment Efficiency 
(%) 
% Drug Content pH 
F1 70.251.86 98.22.04 6.810.02 
F2 75.311.98 98.21.99 6.830.03 
F3 82.561.96 98.72.03 6.840.01 
F4 80.312.12 98.81.76 6.830.04 
F5 76.452.03 98.52.46 6.830.05 
F6 73.610.98 98.42.62 6.840.02 
F7 70.811.68 98.92.24 6.870.04 
F8 67.221.72 99.52.08 6.880.05 
F9 64.351.64 99.61.82 6.840.04 
F10 83.211.96 99.71.08 6.83003 
F11 85.321.08 99.52.04 6.840.01 
F12 82.821.82 99.42.12 6.850.04 
F13 82.351.76 99.62.22 6.870.05 
F14 82.011.98 98.91.92 6.860.04 
F15 66.312.04 98.72.23 6.870.06 
F16 60.091.87 98.51.93 6.880.02 
F17 52.312.03 98.82.42 6.880.04 
F18 81.621.86 99.12.34 6.890.06 
F19 81.891.95 99.12.28 6.830.07 
F20 82.322.23 98.92.14 6.840.05 
 
Characterization of finasteride ethosomal gel 
Scanning Electron Microscopy (SEM) 
The micrographs of the F11 illustrated spherical droplets in the 
nanometer range (Figure. 3).The results indicated that the particles 
were spherical and no drug crystals of particles were visible. The 
figure shows agglomeration of particles due to lipid nature of the 
carriers and sample preparation prior to SEM analysis. Some particle 
shapes deviating from sphericity might be due to the lipid 
modification during process of sample treatment. In addition the 
particle shape depends on the purity of the lipid.  
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Figure. (3). Scanning Electron Microscopy micrograph (a) shape (b) size 
 
Zeta Potential Analysis 
To determine the long-term physical stability of the colloidal systems, 
the zeta potential was evaluated. The ethosomal dispersion of the 
optimized formula had higher zeta potential value, indicating the 
better stability. This resulted from electrostatic repulsion, which could 
prevent the bio-colloids from aggregation of nanoparticles of 
suspension. Zeta potential values higher than -30 mV show good 
physical stability [13], being optimized when they reach 
approximately -60 mV, exhibiting a very good physical stability 
during the shelf-life. In this study zeta potential of the F11 was found 
to be -37.9 mV demonstrating (Fig. 4a) that F11 possess a good 
physical stability since particle aggregation is not likely to occur 
owing to electrostatic repulsion. The similar results were reported by 
dubey et al., (2007) [13] for transdermal delivery of anti-psoriatic 
agent for ethosomes. 
Size Distribution of Finasteride Ethosomal 
Formulations 
The size of ethosomes decreased as the concentration of ethanol 
increased with the largest vesicles size 8.41 nm containing 30% 
ethanol (Fig. 4b). Results obtained in the present investigation are in 
conformity with the results of Touitou et al., (2000) [9]. As the 
phospholipid concentration increases the vesicle size also increases 
and by the increase in ethanol concentration the vesicle size also 
increases, so F11 was found to have an optimum average diameter 
of 8.28 nm. 
 
 
Figure. (4). Zeta potential (a) and Size distribution (b) of optimized 
ethosomal formulations 
In-vitro Drug Release Study from Dialysis Membrane 
In-vitro release studies by using vertical franz diffusion cell was 
performed for all the formulations at 37°C. A graph of % cumulative 
drug release vs time was plotted in figure 5. 
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Figure. 5. In-vitro Drug Release Profile of formulations containing (a) 20% Ethanol (F1-F9), (b) 30% Ethanol (F10-F14), (c) 40, 50 and 60 % Ethanol 
(F15-F20) and (d) F11b and F11b*. 
 
Kinetics of Optimized Ethosomal Gel 
The comparison of the optimized gel of F11b ethosomal suspension 
and F11b* gel containing Free drug was determined. After 
calculating and plotting the release kinetics for the optimized 
formulation of the ethosomal gel i.e. F11b and comparing this with 
the free drug gel formulation F11b*, it was found that the in-vitro drug 
release can be best explained by first order kinetics, as the plots 
showed highest linearity with regression coefficient R2 0.9933 
(Figure. 6). The observations and kinetic model graphs showed that 
the mechanism of drug release was anomalous non-fickian diffusion 
for which n=0.56, followed by higuchi kinetics where ethosomes acts 
as reservoir system for continuous delivery of the drug (Table 4). The 
similar results were reported by Ying et al., (2013) for curcumin 
ethosomes delivery through skin [21]. 
  
.  
Fig. (6). Drug Release kinetics of optimized F11b ethosomal gel  (a) Zero Order Kinetics, (b) First Order Kinetics, (c) Higuchi Plot and (d) Korsmeyer-
Peppas Plot  
Table 4. Regression (R2) values of pharmacokinetic profiles of optimized formulation 
Formulation code Zero order  First order  Higuchi  Korsmeyer-Peppas  
F11b 0.911 0.9933 0.995 0.9919 
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Ex-vivo drug diffusion through rat skin 
After carrying out the in-vitro diffusion studies for all the formulations, 
the best formulation was F11 (30% ethanol and 3% soya lecithin). 
As rat skin showed good correlation with the in-vitro drug release of 
formulation F11, skin permeation studies of F11b was compared with 
the ex-vivo studies of F11b* which is a plain hydroalcoholic gel (fig. 
7). This behaviour probably depended on the increase of the volume 
of the hydro-alcoholic compartment of ethosomes. The similar 
results were obtained in case paclitaxel loaded ethosomes reported 
by Donatella et al., (2012) [20]. 
 
 
Figure. (7). Ex-vivo permeation studies (a) of optimized formulation using rat skin (b) and In-vitro and ex-vivo correlation. 
 
Characterization and Evaluation of Ethosomal Gel 
Determination of Organoleptic Characters, 
Washability and Spreadability 
The organoleptic characters were determined and the color was 
found to be Golden yellow without any greasiness and grittiness. It 
was found that the ethosomal gel prepared can be applied easily, 
smoothly and there was no any skin irritation. The washability test 
was performed and it was found that the applied ethosomes were 
easily washable without leaving any residue on the surface of the 
skin. The Spreadability of the ethosomal gel was also very promise. 
The carbopol concentration of 1.5% was found to be optimum with 
6.25 g. cm/sec, because the less carbopol concentration of 1% 
proved to have less consistency and was unable to apply properly. 
The more carbopol concentration of 2% was found to be more 
viscous and sticky in nature. The similar trend was shown by Sujitha 
et al., (2014) on piroxicam loaded ethosomes [22]. 
Determination of pH, Percentage Drug Content, 
viscosity and Content Uniformity 
The pH of all ethosomal gels was found between 6.0 and 7.0 (Table 
3) that lie in the normal pH range of skin, 4.0-6.8 and hence the 
preparations will be irritation free [22]. The pH of all the ethosomal 
gels was more or less equal to the skin pH, making the formulations 
suitable for application on skin aiding in systemic action. % Drug 
content of all the formulations was determined and was found to 
have a range of 98-100%. This shows that the drug was dispersed 
homogenously throughout the gels. The drug content for F13 
formulation was found to be higher because of the optimum ethanol 
concentration. This shows that drug was dispersed homogenously 
throughout the gels. The Viscosity is optimum for 1.5% carbopol 
concentration since it has good flow and consistency unlike the 1% 
and the 2%, these both have either less or more viscosity compared 
to the optimum 1.5% carbopol. Viscosity of the optimized gel was 
found to have a range of 754-1350cp. The same trend was observed 
by Li et al., (2014) on the viscosity of apigenin ethosomes 
formulation [23]. 
Stability studies 
After 9 weeks there was no change in appearance in ethosomal 
formulations throughout the period of study. Since the stability of 
drug and stability of vesicles are the major determinant for the 
stability of formulation, studies were carried to evaluate total drug 
content at room temperature (27±2°C) and refrigeration temperature 
(4±2°C) after 9 weeks (Table 5). Stability study could not be carried 
out at higher temperature (>room temperature) because 
phospholipid was used as the component for ethosomes and gets 
deteriorated at higher temperature. Loss in percentage of drug was 
not more than 4 percent. Highest drug loss was observed at room 
temperature after 9 weeks as compared to refrigeration temperature. 
Further Ketul et al., (2012) supported by reporting ethosomal gel for 
lipinavir drug [24]. 
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Table 5. Loss in percentage drug release during stability studies of the optimized batch of Ethosomal Gel (F11b). 
 
Formulation code (F11b) Percentage of drug release Loss in percentage 
Initial 
 
4±2° C 82.661.26 0 
27±2° C 82.661.42 0 
After 2 weeks 4±2° C 82.391.38 0.3260.04 
27±2° C 82.251.62 0.4960.12 
After 4 Weeks 4±2° C 81.961.75 0.8460.16 
27±2° C 81.821.16 1.010.24 
After 6weeks 4±2° C 81.681.58 1.180.36 
27±2° C 81.551.82 1.340.28 
After 9 weeks 4±2° C 81.481.24 1.420.14 
27±2° C 81.321.44 1.620.12 
 
Conclusions 
The prepared ethosomes were spherical and discrete in shape. The 
size of vesicles was found to be in the range which is desirable for 
skin penetration. The ethosomes containing 30% w/w ethanol and 
prepared by sonication method showed highest entrapment 
efficiency and transdermal flux and can rapidly penetrate through the 
skin may be because of tiny vesicular size. The pH of the ethosomal 
gel was compatible with skin, easily spreadable and washable. The 
in-vitro percentage drug release studies were carried out and the % 
of drug release was found to be 82.66%. The release mechanism of 
finasteride from gel was higuchi model (r2, 0.99), suddenly released 
and continuously releasing. The zeta potential was found to be -39.7 
mV which indicates good physical stability. Stability studies carried 
out for a period of 9 weeks showed negligible changes in the 
characteristics of ethosomes and further the loss of drug is not more 
than 4 %. Hence it is concluded that a successful ethosomal gel was 
formulated for finasteride. Further this can be exploited 
commercially into a suitable drug formulation.  
Acknowledgments 
The authors are grateful to Aurabindo Pharma Ltd., Hyderabad, India 
for providing gift sample of finasteride for research work and also to 
Dr. K. Abbulu, Principal, Mallareddy Institute of Pharmaceutical 
Sciences, for corrections, english language and excellent facility to 
carry out this work. 
 
 
 
References 
 
[1]. Gangwar S, Singh S, Garg G. 
Ethosomes: A novel tool for drug delivery 
through the skin. J Pharm Res. 2010; 
3(4): 688–691. 
[2]. Ahad A, Aqil M, Kohli K, Chaudhary H, 
Sultana Y, Mujeeb M, Talegaonka S. 
Chemical penetration enhancers: A 
patent review. Expert Opin Ther Pat. 
2009; 19: 969–988. 
[3]. Ahad A, Al-Jenoobi FI, Al-Mohizea AM, 
Aqil M, Kohli K. Transdermal delivery of 
calcium channel blockers for 
hypertension.  Expert Opin Drug Deliv. 
2013: 10: 1137–1153. 
[4]. Schreier H, Bouwstra JA. Liposomes and 
niosomes as topical drug carriers: Dermal 
and Transdermal drug delivery. J 
Controlled Release. 1994; 30: 1–15. 
[5]. Ahad A, Aqil M, Kohli K, Sultana Y, 
Mujeeb M, Ali A. Formulation and 
optimization of nanotransfersomes using 
experimental design technique for 
accentuated transdermal delivery of 
valsartan. Nanomedicine. 2012; 8: 237–
249.  
[6]. Ahad A, Aqil M, Kohli K, Sultana Y, 
Mujeeb M. Enhanced transdermal 
delivery of an antihypertensive agent via 
nanoethosomes: statistical optimization, 
characterization and pharmacokinetic 
assessment. Int J Pharm. 2013; 443: 26–
38. 
[7]. Touitou E, Dayan N, Levi-Schaffer F, 
Piliponsky A. Novel lipid vesicular system 
for enhanced delivery. J Lip Res. 1998; 8: 
113–114. 
[8]. Barry B.W. Novel mechanisms and 
devices to enable successful transdermal 
drug Delivery. Eur J Pharm Sci. 2001; 14: 
101–114. 
[9]. Touitou E, Dayan N, Bergelson L, Godin 
B, Eliaz M. Ethosomes novel vesicular 
carriers for enhanced delivery: 
characterization and skin penetration 
properties. J Cont Release. 2000; 65: 
403–418. 
[10]. Elsayed MA, Abdallah YO, Naggar FV, 
Khalafallah NM. Deformable ethosomes 
and liposomes: Mechanism of enhanced 
skin delivery. Int J Pharm. 2006; 322: 60–
66. 
[11]. Touitou E, Dayan N, Bergelson L, Godin 
B, Eliaz M. Ethosomes-novel vesicular 
carriers for enhanced delivery: 
Characterization and skin penetration 
Sujatha et al International Journal of Drug Delivery 8 (1) 01-11 [2016] 
 
 
  
PAGE | 11 | 
 
 
properties. J Controlled Release. 1999; 
65: 403–18.  
[12]. Touitou E, Godin B, Dayan N, Weiss C, 
Piliponsky A, Levi-Schaffer F. 
Intracellular delivery mediated by an 
ethosomal carrier. Biomaterials. 2001; 
22: 3053–3059. 
[13]. Dubey V, Mishra D, Dutta T, Nahar M, 
Saraf DK, Jain NK. Dermal and 
transdermal delivery of an anti-psoriatic 
agent via ethanolic liposomes. J 
Controlled Release. 2007; 123: 148–154.  
[14]. Span PN, Voller MC, Smals AG, Sweep 
FG, Schalken JA, Feneley MR, Kirby RS. 
Selectivity of finasteride as an in vivo 
inhibitor of 5 alpha-reductase isozyme 
enzymatic activity in the human prostate. 
J Urol. 1999; 161: 332–337. 
[15]. Berge V, Swartzendruber VB, Geest J. 
Development of an optimal protocol for 
the ultra structural examination of skin by 
transmission electron microscopy. J 
Microscopy. 1997; 187(2): 125–133. 
[16]. Maghraby GM, Williams AC, Barry BW. 
Oestradiol skin delivery from ultra 
formable liposomes: refinement of 
surfactant concentration. Int J Pharm. 
2000; 196: 63–74. 
[17]. Cevc G, Schatzlein A, Blume G. 
Transdermal drug carriers: Basic 
properties, optimization & transfer 
efficiency in case of epicutaneously 
applied peptides. J Controlled Release. 
1995; 36: 3–16.  
[18]. Lopez-Pinto JM, Gonzalez-Rodriguez 
ML, Rabasco AM. Effect of cholesterol 
and ethanol on dermal delivery from 
DPPC liposomes. Int J Pharm. 2005; 298: 
1–12.  
[19]. Toll R, Jacobi U, Richter H, Lademann J, 
Schaefer H, Blume U. Penetration profile 
of microspheres in follicular targeting of 
terminal hair follicles. J Invest Dermatol. 
2004; 123: 168–176.  
[20]. Donatella P, Christian C, Elena T, Felisa 
C, Massimo F. Paclitaxel-loaded 
ethosomes: Potential treatment of 
squamous cell carcinoma, a malignant 
transformation of actinic keratoses. Eur J 
Pharm Biopharm. 2012; 81: 102–112. 
[21]. Ying ZZ, Cui TL, Yi Z,  Jian X,  Ya PZ, 
Yan YX, Zhi GF, Chong YX, Ji LT. 
Selection of high efficient transdermal 
lipid vesicle for curcumin Skin delivery. Int 
J Pharm. 2013; 454: 302–309.  
[22]. Sujitha B, Krishnamoorthy B, 
Muthukumaran M. Formulation and 
Evaluation of Piroxicam Loaded 
Ethosomal Gel for Transdermal Delivery. 
Int J Adv Pharm Gen Res. 2014; 2(1):34–
45. 
[23]. Li NS, Yong TZ, Qin W, Ling X, Nian PF. 
Enhanced in vitro and in vivo skin 
deposition of apigenin delivered using 
ethosomes. Int J Pharm. 2014; 460: 280–
288. 
[24]. Ketul KP, Praveen K, Hetal PT. 
Formulation of Niosomal Gel for 
Enhanced Transdermal Lopinavir 
Delivery and Its Comparative Evaluation 
with Ethosomal Gel, AAPS Pharm Sci 
Tech. 2012; 13(4): 1502–1510.   
 
 
